Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in ENLV — Enlivex Ltd.

CIK 886982 NEW YORK, NY
Back to ENLV Full portfolio

Position in ENLV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$49,179
-$45,767 QoQ
Shares Held
5,961
-12.4% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 25 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENLV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. ENLV ranks #339 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in ENLV

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $49,179 89,417
2026-03-31 $94,946 102,093
2024-09-30 $23,410 13,935
2024-06-30 $16,229 11,429
2023-06-30 $29,677 11,297
2023-03-31 $68,686 18,870
2022-12-31 $74,459 18,908
2022-09-30 $88,098 20,729
2022-03-31 $68,225 12,205
2021-03-31 $144,014 12,986